Trademarkia Logo

Canada

C$
Trademark Search in Canada
QUAISAR Drug Design Platform

View On IC.GC.CA

QUAISAR Drug Design Platform
SEARCHED

on 19 Mar 2024

Last Applicant/ Owned by

Psivant Therapeutics. Inc.

451 D StreetBoston MA 02210

US

Serial Number

2247369 filed on 20th Jan 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

QUAISAR Drug Design Platform

Trademark usage description

computer software for the identification and design of molecular drug candidates for use in the field of pharmaceutical drug discovery and development Read More

Classification Information

Class [009]
Computer software for the identification and design of molecular drug candidates for use in the field of pharmaceutical drug discovery and development; computer software for storing, managing, tracking, processing, analyzing and reporting data in the field of molecular drug engineering and design; computer hardware and software for entering, collecting, processing, analyzing, communicating, processing, receiving, recording, storing and transmitting data, pictures and information all for the identification and design of molecular drug candidates for use in the field of pharmaceutical drug discovery and development; computer software for application and database integration; downloadable and recorded computer software for collecting, analyzing, reporting and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded computer software for genetic evaluation and identification of diseases, health conditions and indicators and genetic mutations for scientific, medical, diagnostic, treatment and research purposes; downloadable and recorded computer software for use in diagnosing medical conditions, prescribing medical treatment and prescriptions, planning clinical trials and predicting clinical trial results, finding patients for clinical trials, analyzing medical data and images, data analysis and development of pharmaceuticals and chemical compounds; downloadable and recorded computer software for collecting, analyzing, reporting and tracking data and information in the fields of clinical trial management and patient engagement.

Classification kind code

12

Class [042]
Analysis of technical data by computer; pharmaceutical drug discovery services; pharmaceutical and medical biotechnology research and development services; discovery services for the use of drugs; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery; conducting scientific and pharmaceutical research, namely, analyzing scientific and pharmaceutical data for the screening and identification of molecular interactions, compounds and for the detection of toxicity, all for use in the field of pharmaceutical drug discovery and development; provision of research information in the scientific, pharmaceutical and agrochemical fields via a website; scientific and pharmaceutical research services in the field of artificial intelligence for the identification of molecules and compounds for drug discovery and chemical development; bioinformatics services, namely, the use of a combination of biology, computer science, computer technology, mathematics and statistics for the analysis and interpretation of biological data; computer-aided design of molecules; scientific and biological research, namely, identification of biological targets, biological networks and biological pathways as targets for novel molecular drug candidates; computer aided diagnostic and screening services for scientific research purposes in the field of pharmaceutical drug discovery and development; software as a service (SaaS) comprising software for diagnosing medical conditions, prescribing medical treatments and prescriptions, planning clinical trials and predicting clinical trial results, finding patients for clinical trials, medical image analysis, data analysis and development of pharmaceuticals and chemical compounds; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, and biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement.

Classification kind code

12

Mark Details

Serial Number

2247369

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 19th Mar 2024		Search Recorded
Submitted for opposition 256
on 23rd Jan 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 24th Nov 2023		Agent Changed
Submitted for opposition 80
on 16th Nov 2023		Change of Title Registered
Submitted for opposition 48
on 7th Jun 2023		Agent Changed
Submitted for opposition 257
on 23rd Mar 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 22nd Mar 2023		Created
Submitted for opposition 31
on 22nd Mar 2023		Formalized
Submitted for opposition 228
on 20th Jan 2023		International Registration
Submitted for opposition 30
on 20th Jan 2023		Filed